Fda Laws: Creating A Safer Food Environment

The Food and Drug Administration (FDA) enforces laws and regulations to ensure the safety of the US food supply, including food and dietary supplements. The FDA also regulates the manufacture, distribution, and marketing of tobacco products. The FDA has the authority to issue standards for food and conduct factory inspections. The FDA works with other federal agencies, such as the Department of Health and Human Services (HHS), to review and approve proposed rules and regulations. The FDA's rulemaking procedures are derived from US law, Executive Orders, and the FDA's internal regulations. The FDA assists state, local, and tribal agencies in regulating the retail food and foodservice industries, providing guidance, training, and technical assistance.

Requirements for nutrition labelling

The U.S. Food and Drug Administration (FDA) has specific requirements for nutrition labelling on packaged foods and drinks. In 2016, the FDA updated these requirements based on new scientific information, nutrition research, and public input. This was the first major change to the nutrition label in over 20 years, and it was designed to help consumers make informed food choices that contribute to a healthy diet. The updated label includes information on calories, serving sizes, and added sugars.

The FDA's nutrition labelling requirements are part of the agency's broader efforts to improve public health and consumer protection. The FDA is mandated by law to publish regulations in the Federal Register, which is the federal government's official publication for notifying the public of agency actions. These regulations can address specific problems or known health hazards, such as egg safety, or they can be administrative in nature, such as citizen petition regulations.

The FDA's rulemaking procedures are outlined in U.S. law, Executive Orders (EOs), and the FDA's own regulations. The most common process for issuing rules is the "notice and comment rulemaking" process, which begins with the FDA issuing a proposed rule or "notice of proposed rulemaking" (NPRM). The proposed rule is then reviewed by other parts of the federal government, including the Department of Health and Human Services (HHS) and non-HHS agencies for rules with broader implications.

In addition to nutrition labelling, the FDA has implemented other initiatives to improve nutrition and reduce preventable death and disease related to poor nutrition. For example, the FDA announced the Nutrition Innovation Strategy in 2018, which includes consumer education as a key element. The FDA has also developed educational resources for middle and high school students, health professionals, and educators to help them understand and use the Nutrition Facts label to make informed food choices.

Guidance for food and dietary supplements

The FDA develops regulations based on the laws set forth in the Federal Food, Drug, and Cosmetic Act and other laws under which the FDA operates. The FDA also issues guidance documents containing non-binding recommendations to help the industry understand and comply with all regulations and laws. These guidance documents do not create or confer any rights for or on any person and do not bind the FDA or the public.

The FDA regulates both finished dietary supplement products and dietary ingredients. The FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), manufacturers and distributors of dietary supplements and dietary ingredients are prohibited from marketing products that are adulterated or misbranded. The FDA has the authority to take action against any adulterated or misbranded dietary supplement product after it reaches the market.

The FDA provides guidance on various topics related to dietary supplements, including:

• Labeling requirements: Guidance documents provide instructions and recommendations on how to properly label dietary supplements, including making nutrient content claims, health claims, and statements of nutritional support.
• Safety evaluations: The FDA guides firms on evaluating the safety and labeling of their products to ensure they meet the requirements of the Federal Food, Drug, and Cosmetic Act as amended by DSHEA and FDA regulations.
• Structure/function claims: The FDA provides information on how to submit structure/function claims for dietary supplements and how to view previous submissions.
• Highly concentrated caffeine: Guidance is provided on the use of highly concentrated caffeine in dietary supplements, including considerations for safety and compliance.
• Quantitative labeling: Draft guidance is available for the quantitative labeling of dietary supplements containing live microbials.
• Distinguishing liquid dietary supplements from beverages: This guidance helps manufacturers and distributors differentiate between liquid dietary supplements and beverages to ensure proper regulation and compliance.
• Substances added to foods: The FDA provides guidance on the considerations and regulations regarding substances added to foods, including supplements and beverages.
• Vitamin D supplements: Guidance is provided specifically for liquid vitamin D dietary supplements to ensure compliance with regulations.

The FDA also provides a range of resources and tools to support the industry, such as the Small Entity Compliance Guides and the Guidance for Small Businesses, which offer detailed instructions and recommendations for complying with relevant regulations.

Medical Device Amendments

The Medical Device Amendments, also known as the Medical Device Regulation Act, were signed into law by US President Gerald R. Ford on May 28, 1976. The amendments were introduced to address the safety and effectiveness of medical devices following a US Senate finding that faulty devices had caused 10,000 injuries and 731 deaths.

The legislation amended the Food, Drug, and Cosmetic Act of 1938, which was passed after a toxic elixir marketed as a cure killed 107 people, including many children. The 1976 amendments provided for the classification of medical devices intended for human use based on their safety and effectiveness, with three classes defined by the level of risk associated with the device.

Class I devices are considered low-risk, with sufficient information to assure safety and effectiveness. These devices are not intended to support or sustain human life or prevent health impairment, and they do not pose a potential unreasonable risk of illness or injury. Class II devices are considered moderate-risk, with insufficient information to assure safety and effectiveness under Class I controls. Class III devices are high-risk, where there is insufficient information to classify them as Class I or II, and they are intended to support or sustain human life, prevent health impairment, or present a potential unreasonable risk of illness or injury.

The Medical Device Amendments also authorized the FDA to require manufacturers to perform post-market surveillance on permanently implanted devices, order device recalls, and impose civil penalties for violations of the FD&C Act. The amendments created the De Novo program, which allowed low-to-moderate-risk devices to be classified as Class I or II instead of automatically being placed in Class III. The FDA was also granted the authority to collect user fees for select medical device premarket submissions, and the Small Business Determination (SBD) program was enacted to reduce premarket approval fees for qualifying small businesses.

Tobacco Control Act

The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) was signed into law by President Barack Obama on June 22, 2009. The Act gives the Food and Drug Administration (FDA) the authority to regulate the tobacco industry, including the manufacture, distribution, and marketing of tobacco products.

The Tobacco Control Act was introduced to address the decision that the Clinton administration's FDA had "overreached" its authority. The Act includes specific restrictions on marketing tobacco products to children and gives the FDA the power to take further action to protect public health. For example, the Act requires tobacco companies to seek FDA approval for new tobacco products and places limits on advertising to minors. It also bans flavored cigarettes, with the exception of menthol and tobacco, and requires larger and more visible health warnings on smokeless tobacco packages and advertisements.

The Tobacco Control Act also preserves the authority of state, local, and tribal governments to regulate tobacco products in specific respects. It requires tobacco company owners and operators to register annually and open their facilities to FDA inspection every two years. The Act allows the FDA to implement standards for tobacco products, such as regulating nicotine and ingredient levels, and bans cigarettes with characterizing flavors.

The law was criticized by some as being ineffectual, arguing that without the power to eliminate nicotine, the reduction of nicotine levels may lead to increased cigarette smoke inhalation by existing smokers. The Act has also been criticized for creating financial and regulatory barriers for the introduction of competing products to the US market, making it more difficult to promote safer smokeless alternatives to cigarettes.

Public health and consumer protections

The Food and Drug Administration (FDA) is responsible for enforcing laws enacted by the US Congress and regulations established by the Agency to protect the public's health and safety. The FDA's mission is to protect consumers' health, safety, and pocketbooks.

The Federal Food, Drug, and Cosmetic Act, with its numerous amendments, is the basic food and drug law in the US. It is intended to assure consumers that foods are pure, safe to eat, and produced under sanitary conditions. The law also ensures that drugs, devices, and cosmetics are safe and effective for their intended uses and that all labelling and packaging are truthful, informative, and not deceptive. The FDA's portion of the CFR interprets the Federal Food, Drug, and Cosmetic Act and related statutes. Section 21 of the CFR contains most of the regulations pertaining to food and drugs.

The FDA also regulates the manufacturing, marketing, and distribution of tobacco products to protect public health and reduce tobacco use by minors. The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) was enacted in 2009, giving the FDA authority over the tobacco industry.

The FDA's regulations for clinical trials, in effect since the 1970s, address good clinical practices and human subject protection. The Medical Device Amendments of 1976 were enacted after faulty medical devices caused thousands of injuries and hundreds of deaths. The law applied safety and effectiveness safeguards to new devices.

The FDA plays a significant role in the nation's counterterrorism capability and is part of the Department of Health and Human Services (HHS). The FDA publishes regulations in the Federal Register, the federal government's official publication for notifying the public of agency actions.

Frequently asked questions